Breach of fiduciary duty
Search documents
Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.
Prnewswire· 2025-11-24 15:00
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Accessibility StatementSkip Navigation MILWAUKEE, Nov. 24, 2025 /PRNewswire/ -- Ademi & Fruchter LLP is investigating possible securities fraud claims against DexCom, Inc. (NASDAQ: DXCM). The investigation results from inaccurate statements DexCom made regarding its business operations and prospects. Click here to join our inv ...
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
Globenewswire· 2025-11-20 20:13
BALA CYNWYD, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Exact Sciences Corporation (“Exact Sciences” or the “Company”) (Nasdaq – EXAS) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the acquisition of the Company by Abbott (NYSE - ABT) for $105.00 per common share in cash, representing a total equity value of approximately $21 billion. The ...
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Performant Healthcare, Inc. (Nasdaq - PHLT)
GlobeNewswire News Room· 2025-08-01 18:47
Core Viewpoint - The law office of Brodsky & Smith is investigating potential claims against the Board of Directors of Performant Healthcare for possible breaches of fiduciary duty related to the sale of the Company to Machinify at a price of $7.75 per share in cash [1][2]. Group 1 - The investigation focuses on whether the Board of Performant Healthcare failed to conduct a fair process in the sale, particularly regarding the fairness of the consideration provided to shareholders [2]. - The transaction involves Machinify acquiring all outstanding shares of Performant Healthcare for a total cash consideration of $7.75 per share [1]. Group 2 - Brodsky & Smith is a litigation law firm with a strong track record in representing shareholders in securities and class action lawsuits, having successfully recovered millions for clients [4].
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of AvidXchange Holdings, Inc. (Nasdaq – AVDX)
GlobeNewswire News Room· 2025-06-17 21:50
Core Viewpoint - AvidXchange Holdings, Inc. is under investigation for potential breaches of fiduciary duty by its Board of Directors in relation to its sale to TPG, which values the company at $2.2 billion with a cash offer of $10.00 per share [1][2]. Group 1 - The investigation focuses on whether the AvidXchange Board failed to conduct a fair process and whether the sale price reflects fair value for shareholders [2]. - TPG's acquisition of AvidXchange involves purchasing all outstanding shares of the company's common stock [1].